-
Product Insights
NewStomatitis (Sore Mouth) – Drugs In Development, 2024
Empower your strategies with our Stomatitis (Sore Mouth) – Drugs In Development, 2024 report and make more profitable business decisions. Stomatitis is inflammation of the mouth and lips. It refers to any inflammatory process affecting the mucous membranes of the mouth and lips, with or without oral ulceration. The inflammation can be the result of conditions within the mouth itself, such as poor oral hygiene, poorly fitted dentures, or mouth burns from hot food or drinks. It may also be caused...
-
Product Insights
NewOral Mucositis – Drugs In Development, 2024
Empower your strategies with our Oral Mucositis – Drugs In Development, 2024 report and make more profitable business decisions. Oral mucositis is the most common type of mucositis. It is a debilitating complication of cancer surgery, chemotherapy, and radiation. Symptoms include change in mucosa color, hyposalivation, a change in the integrity of the mucosa, and the presence of edema on the lips and/or the tongue. Treatment includes oral decontamination (mouth care) and oral debridement. The Oral Mucositis drugs in development market...
-
Product Insights
Oral Mucositis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Oral Mucositis Clinical Trial Report Overview A total of 506 oral mucositis clinical trials were conducted as of December 2023. The following are some of the key highlights of the oral mucositis clinical trial market: Asia-Pacific led the oral mucositis clinical trials landscape with more than 30% of the clinical trials conducted as of December 2023. China had the highest average patient enrollment of oral mucositis clinical trials, as of December 2023. In 2023, Amgen Inc. conducted the highest number of...